微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.74% | 100% | 131.71% | 79/131 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -2.33% | -206.07% | -220.28% | 105/131 | 3.1% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 1.94% | -57.73% | 122.99% | 88/131 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 0.87% | -65.2% | 135.14% | 88/131 | 3.08% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.37% | -86.19% | -83.18% | 94/131 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 2.2% | 322.9% | -52.07% | 92/131 | 5.12% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 4.59% | -33.19% | 83.6% | 67/131 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 2.5% | -44.44% | -6.72% | 71/131 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 2.68% | 0% | 371.53% | 47/131 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | -0.99% | -133% | -114.37% | 112/131 | 13.36% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 6.87% | -10.89% | 52.67% | 72/131 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 4.5% | 16.88% | 67.91% | 72/131 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 2.68% | 31.37% | -10.4% | 60/131 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 2.99% | 148.88% | -61.2% | 113/131 | 17.4% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 7.71% | 12.88% | 100.26% | 75/131 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 3.85% | 3.77% | 88.73% | 93/131 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2.04% | 12.71% | 133.33% | 72/131 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | -6.12% | -156.93% | -189.6% | 119/131 | 25.69% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 6.83% | -24.7% | 84.1% | 63/131 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 3.71% | -35.92% | 104.97% | 81/131 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 1.81% | -36.71% | -83.16% | 45/131 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 10.75% | 66.93% | 18.52% | 74/131 | 14.38% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 9.07% | 20.93% | 56.65% | 35/131 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 5.79% | 26.7% | 102.45% | 37/131 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 2.86% | 20.17% | -55.59% | 20/131 | 2.72% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 6.44% | -31.71% | -14.13% | 83/131 | 12.98% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 7.5% | -4.82% | 64.11% | 33/131 | 7.16% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 4.57% | -6.54% | 92.02% | 31/131 | 3.21% | 明德生物 | 14.54% | 行业排名> |
| 2018-03-31 | 2.38% | 15.53% | -74.76% | 26/131 | 2.62% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 9.43% | -1.87% | 19.67% | 66/131 | 13.82% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 7.88% | 13.38% | 61.15% | 27/131 | 9.43% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 4.89% | 6.07% | 137.38% | 34/131 | 5.9% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 2.06% | -3.29% | -78.56% | 24/131 | 2.66% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 9.61% | 18.06% | 38.27% | 53/131 | 16.21% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 6.95% | 18.8% | 50.76% | 20/131 | 8.69% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 4.61% | 16.12% | 116.43% | 27/131 | 6.26% | 明德生物 | 23.29% | 行业排名> |
| 2016-03-31 | 2.13% | 5.97% | -73.83% | 16/131 | 2.14% | 健帆生物 | 7.75% | 行业排名> |
| 2015-12-31 | 8.14% | -6.33% | 39.15% | 48/131 | 15.95% | 大博医疗 | 55.39% | 行业排名> |
| 2015-09-30 | 5.85% | -9.58% | 47.36% | 22/131 | 7.79% | 鱼跃医疗 | 17.33% | 行业排名> |
| 2015-06-30 | 3.97% | -16.24% | 97.51% | 31/131 | 7.77% | 明德生物 | 29.93% | 行业排名> |
| 2015-03-31 | 2.01% | -24.15% | -76.87% | 22/131 | 3.2% | 中源协和 | 14.44% | 行业排名> |